Yıl: 2023 Cilt: 54 Sayı: 2 Sayfa Aralığı: 116 - 126 Metin Dili: İngilizce DOI: 10.32552/2023.ActaMedica.842 İndeks Tarihi: 23-07-2023

High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach

Öz:
Background: Heart failure (HF) is a common disease which is one of the most common causes of hospitalization. Although mortality rates are decreasing, readmission rates are still quite high. Objectives: We aimed to investigate the risk factors for readmission and death in patients who were hospitalized due to HF. Design and Setting: Retrospective study, Hacettepe University, Ankara, Turkey Methods: Patients hospitalized between 1 January 2014 to 31 December 2018 with the primary diagnosis of HF were included. Outcome variables were risk factors for 30-day all- caused readmission, 30-day HF related readmission, mortality. Results: All-cause 30-day readmission rate was 34.8% and HF-related 30- day readmission rate was 21.2%. The factors associated with increased all-caused 30-day readmission were male gender, hyperlipidemia, chronic liver disease, malignancy. The factors associated with increased HF-related 30-day readmission were hyperlipidemia, chronic liver disease, inflammatory rheumatologic diseases, malignancy. Use of ACE-i was found to be protective against all-cause and HF-related 30-day readmission. Factors associated with mortality were ejection fraction <30%, chronic liver disease, acute kidney injury, hypoalbuminemia at the time of admission. Conclusions: Nearly one third of patients in this cohort who were hospitalized with a primary diagnosis of HF were readmitted in the following 30 days. Having certain chronic diseases and conditions were associated with an increased risk for readmission and mortality. These findings point out to the special needs of HF patients, who require a proactive, integrated and multidisciplinary management strategy to control the risk factors and to improve the inpatient and transitional stages in the hospital.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • [1] Lesyuk W, Kriza C, Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a systematic review 2004–2016. BMC cardiovascular disorders. 2018;18(1):74.
  • [2] Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. Journal of the American College of Cardiology. 2014;63(12):1123-1133.
  • [3] Adams Jr KF, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). American heart journal. 2005;149(2):209-216.
  • [4] Ponikowski P, Anker SD, AlHabib KF, et al. Heart failure: preventing disease and death worldwide. ESC heart failure. 2014;1(1):4-25.
  • [5] Kang S-M, Cho M-C. Prognostic factors in hospitalization for heart failure in Asia. Heart failure clinics. 2015;11(4):543- 550.
  • [6] Dharmarajan K, Rich MW. Epidemiology, pathophysiology, and prognosis of heart failure in older adults. Heart failure clinics. 2017;13(3):417-426.
  • [7] Desai AS, Stevenson LW. Rehospitalization for heart failure: predict or prevent? Circulation. 2012;126(4):501-506.
  • [8] Mirkin KA, Enomoto LM, Caputo GM, Hollenbeak CS. Risk factors for 30-day readmission in patients with congestive heart failure. Heart & Lung. 2017;46(5):357-362.
  • [9] Huynh Q, Saito M, Blizzard C, Eskandari M, Johnson B, Adabi G. Prediction of 30-day rehospitalization or death among heart failure patients: roles of non-clinical and clinical data. J Card Fail. 2015;21(5):374-381.
  • [10] Saito M, Negishi K, Marwick TH. Meta-analysis of risks for short-term readmission in patients with heart failure. The American journal of cardiology. 2016;117(4):626-632.
  • [11] Vader JM, LaRue SJ, Stevens SR, et al. Timing and causes of readmission after acute heart failure hospitalization— insights from the Heart Failure Network Trials. Journal of cardiac failure. 2016;22(11):875-883.
  • [12] Chamberlain RS, Sond J, Mahendraraj K, Lau CS, Siracuse BL. Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale. International journal of general medicine. 2018;11:127.
  • [13] Su A, Al’Aref SJ, Beecy AN, Min JK, Karas MG. Clinical and Socioeconomic Predictors of Heart Failure Readmissions: A Review of Contemporary Literature. Elsevier; 2019:1304- 1320.
  • [14] Goldgrab D, Balakumaran K, Kim MJ, Tabtabai SR. Updates in heart failure 30-day readmission prevention. Heart failure reviews. 2019;24(2):177-187.
  • [15] Van Walraven C, Bennett C, Jennings A, Austin PC, Forster AJ. Proportion of hospital readmissions deemed avoidable: a systematic review. Cmaj. 2011;183(7):E391-E402.
  • [16] Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European heart journal. 2020;41(1):111-188.
  • [17] Group KDIGOAKIW. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1-138.
  • [18] 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2020;43(Supplement 1):S14-S31. doi:10.2337/dc20-S002
  • [19] Ponikowski P,Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European journal of heart failure. 2016;18(8):891-975.
  • [20] Farré N, Vela E, Clèries M, et al. Medical resource use and expenditure in patients with chronic heart failure: a population based analysis of 88 195 patients. European journal of heart failure. 2016;18(9):1132-1140.
  • [21] Bytyçi I, Bajraktari G. Mortality in heart failure patients. Anatolian journal of cardiology. 2015;15(1):63.
  • [22] Allen LA, Tomic KES, Smith DM, Wilson KL, Agodoa I. Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure. Circulation: Heart Failure. 2012;5(6):672-679.
  • [23] Davis JD, Olsen MA, Bommarito K, et al. All-payer analysis of heart failure hospitalization 30-day readmission: comorbidities matter. The American journal of medicine. 2017;130(1):93. e9-93. e28.
  • [24] Stewart S, Horowitz JD. Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation. 2002;105(24):2861- 2866.
  • [25] Curtis JP, Sokol SI, Wang Y, et al. The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. Journal of the American College of Cardiology. 2003;42(4):736-742.
  • [26] Garg R,Yusuf S, Bussmann W, et al. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Jama. 1995;273(18):1450-1456.
  • [27] Khalil ME, Basher AW, Brown EJ, Alhaddad IA. A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. Journal of the American College of Cardiology. 2001;37(7):1757-1764.
  • [28] Anker SD, Clark AL, Winkler R, et al. Statin use and survival in patients with chronic heart failure—results from two observational studies with 5200 patients. International journal of cardiology. 2006;112(2):234-242.
  • [29] Yousufuddin M, Takahashi PY, Major B, et al. Association between hyperlipidemia and mortality after incident acute myocardial infarction or acute decompensated heart failure: a propensity score matched cohort study and a meta-analysis. BMJ open. 2019;9(12)
  • [30] Valbusa F, Bonapace S, Grillo C, et al. Nonalcoholic fatty liver disease is associated with higher 1-year all-cause rehospitalization rates in patients admitted for acute heart failure. Medicine. 2016;95(7)
  • [31] Lonardo A, Sookoian S, Pirola CJ, Targher G. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism. 2016;65(8):1136-1150.
  • [32] Correale M, Tarantino N, Petrucci R, et al. Liver disease and heart failure: Back and forth. European journal of internal medicine. 2018;48:25-34.
  • [33] Fang JC, Ewald GA, Allen LA, et al. Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. Journal of cardiac failure. 2015;21(6):519-534.
  • [34] Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. Journal of the American College of Cardiology. 2006;47(10):1987-1996.
  • [35] Wright K, Crowson CS, Gabriel SE. Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. Heart failure clinics. 2014;10(2):339-352.
  • [36] Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nature reviews Rheumatology. 2015;11(12):693.
  • [37] Piper S, McDonagh T. Heart failure and chemotherapeutic agents. Future cardiology. 2015;11(4):453-470.
  • [38] Nishi I, Seo Y, Hamada-Harimura Y, et al. Nutritional screening based on the controlling nutritional status (CONUT) score at the time of admission is useful for long-term prognostic prediction in patients with heart failure requiring hospitalization. Heart and vessels. 2017;32(11):1337-1349.
  • [39] Bonilla-Palomas JL, Gámez-López AL, Castillo-Domínguez JC, et al. Nutritional intervention in malnourished hospitalized patients with heart failure. Archives of medical research. 2016;47(7):535-540.
  • [40] Roshanghalb A, Mazzali C, Lettieri E. Multi-level models for heart failure patients’ 30-day mortality and readmission rates: the relation between patient and hospital factors in administrative data. BMC Health Services Research. 2019;19(1):1-12.
  • [41] Omar H, Guglin M. Longer-than-average length of stay in acute heart failure. Herz. 2018;43(2):131-139.
  • [42] Cotter G, Davison BA, Milo O, et al. Predictors and associations with outcomes of length of hospital stay in patients with acute heart failure: results from VERITAS. Journal of cardiac failure. 2016;22(10):815-822.
  • [43] Wright S, Verouhis D, Gamble G, Swedberg K, Sharpe N, Doughty R. Factors influencing the length of hospital stay of patients with heart failure. European journal of heart failure. 2003;5(2):201-209.
  • [44] Chava R, Karki N, Ketlogetswe K, Ayala T. Multidisciplinary rounds in prevention of 30-day readmissions and decreasing length of stay in heart failure patients: A community hospital based retrospective study. Medicine. 2019;98(27)
  • [45] van Walraven C, Jennings A, Forster AJ. A meta analysis of hospital 30 day avoidable readmission rates. Journal of evaluation in clinical practice. 2012;18(6):1211-1218.
  • [46] Comín-Colet J, Verdú-Rotellar JM, Vela E, et al. Efficacy of an integrated hospital-primary care program for heart failure: a population-based analysis of 56 742 patients. Revista Española de Cardiología (English Edition). 2014;67(4):283- 293.
  • [47] Fleming LM, Kociol RD. Interventions for heart failure readmissions: successes and failures. Current heart failure reports. 2014;11(2):178-187.
  • [48] Takeda A, Taylor SJ, Taylor RS, Khan F, Krum H, Underwood M. Clinical service organisation for heart failure. Cochrane database of systematic reviews. 2012;(9)
  • [49] Ambrosy AP, Pang PS, Khan S, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. European heart journal. 2013;34(11):835- 843.
  • [50] Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar Jacob JM. Medication adherence interventions improve heart failure mortality and readmission rates: systematic review and meta analysis of controlled trials. Journal of the American Heart Association. 2016;5(6):e002606.
APA Bolek H, cetik s, CEYLAN F, Bolek E, Uyaroğlu O, Tanriover M (2023). High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. , 116 - 126. 10.32552/2023.ActaMedica.842
Chicago Bolek Hatice,cetik sila,CEYLAN Furkan,Bolek Ertugrul Cagri,Uyaroğlu Oğuz Abdullah,Tanriover Mine Durusu High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. (2023): 116 - 126. 10.32552/2023.ActaMedica.842
MLA Bolek Hatice,cetik sila,CEYLAN Furkan,Bolek Ertugrul Cagri,Uyaroğlu Oğuz Abdullah,Tanriover Mine Durusu High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. , 2023, ss.116 - 126. 10.32552/2023.ActaMedica.842
AMA Bolek H,cetik s,CEYLAN F,Bolek E,Uyaroğlu O,Tanriover M High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. . 2023; 116 - 126. 10.32552/2023.ActaMedica.842
Vancouver Bolek H,cetik s,CEYLAN F,Bolek E,Uyaroğlu O,Tanriover M High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. . 2023; 116 - 126. 10.32552/2023.ActaMedica.842
IEEE Bolek H,cetik s,CEYLAN F,Bolek E,Uyaroğlu O,Tanriover M "High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach." , ss.116 - 126, 2023. 10.32552/2023.ActaMedica.842
ISNAD Bolek, Hatice vd. "High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach". (2023), 116-126. https://doi.org/10.32552/2023.ActaMedica.842
APA Bolek H, cetik s, CEYLAN F, Bolek E, Uyaroğlu O, Tanriover M (2023). High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. Acta Medica, 54(2), 116 - 126. 10.32552/2023.ActaMedica.842
Chicago Bolek Hatice,cetik sila,CEYLAN Furkan,Bolek Ertugrul Cagri,Uyaroğlu Oğuz Abdullah,Tanriover Mine Durusu High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. Acta Medica 54, no.2 (2023): 116 - 126. 10.32552/2023.ActaMedica.842
MLA Bolek Hatice,cetik sila,CEYLAN Furkan,Bolek Ertugrul Cagri,Uyaroğlu Oğuz Abdullah,Tanriover Mine Durusu High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. Acta Medica, vol.54, no.2, 2023, ss.116 - 126. 10.32552/2023.ActaMedica.842
AMA Bolek H,cetik s,CEYLAN F,Bolek E,Uyaroğlu O,Tanriover M High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. Acta Medica. 2023; 54(2): 116 - 126. 10.32552/2023.ActaMedica.842
Vancouver Bolek H,cetik s,CEYLAN F,Bolek E,Uyaroğlu O,Tanriover M High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach. Acta Medica. 2023; 54(2): 116 - 126. 10.32552/2023.ActaMedica.842
IEEE Bolek H,cetik s,CEYLAN F,Bolek E,Uyaroğlu O,Tanriover M "High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach." Acta Medica, 54, ss.116 - 126, 2023. 10.32552/2023.ActaMedica.842
ISNAD Bolek, Hatice vd. "High 30-day readmission rates in hospitalized patients with heart failure: Strengthening the need for a multidisciplinary and integrated approach". Acta Medica 54/2 (2023), 116-126. https://doi.org/10.32552/2023.ActaMedica.842